Skip to content

Zydus Lifesciences hits 52-week high on USFDA approval for osteoporosis drug

Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of $1.9 million in the United States.

Read More

​ Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of $1.9 million in the United States. Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of $1.9 million in the United States.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish